Novedades en arritmias y estimulación cardiaca en 2013

Almendral, Jesús; Pombo, Marta; Martı́nez-Alday, Jesús; González-Rebollo, José M.; Rodríguez‐Font, Enrique; Martínez-Ferrer, José; Castellanos, Eduardo; García-Fernández, Francisco Javier; Ruiz-Mateas, Francisco

doi:10.1016/j.recesp.2013.12.014

Cited by 9 publications

(3 citation statements)

References 69 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…21 -23 Data from the Paediatric Radiofrequency Ablation Registry and the study for Prospective Assessment after Paediatric Cardiac Ablation reported a complication rate ranging from 3% to 4.2%. 22 Prolonged radiation exposure is of particular concern in children. In this survey, almost all the centres reported no excess in complications of catheter ablation in children compared with adults.…”

Section: Prophylactic Therapymentioning

confidence: 99%

How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey

et al. 2014

View full text Add to dashboard Cite

The aim of this survey was to provide insight into current practice regarding the management of paediatric arrhythmias in Europe. The survey was based on a questionnaire sent via the Internet to the European Heart Rhythm Association (EHRA) electrophysiology research network centres. The following topics were explored: patient and treatment selection, techniques and equipment, treatment outcomes and complications. The vast majority of paediatric arrhythmias concerns children older than 1 year and patients with grown-up congenital heart disease. In 65% of the hospitals there is a specialized paediatric centre, and the most commonly observed arrhythmias include Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardias (90.24%). The medical staff performing paediatric catheter ablations in Europe are mainly adult electrophysiology teams (82.05% of the centres). Radiofrequency is the preferred energy source used for paediatric arrhythmia ablation. Catheter ablation is only chosen if two or more antiarrhythmic drugs have failed (94.59% of the centres). The majority of the centres use flecainide (37.8%) or atenolol (32.4%) as their first choice drug for prevention of recurrent supraventricular arrhythmias. While none of the centres performed catheter ablation in asymptomatic infants with pre-excitation, 29.7% recommend ablation in asymptomatic children and adolescents. The preferred choice for pacemaker leads in infants less than 1 year old is implantation of epicardial leads in 97.3% of the centres, which continues to be the routine even in patients between 1 and 5 years of age as reported by 75.68% of the hospitals. Almost all centres (94.59%) report equally small number of complications of catheter ablation in children (aged 1-14 years) as observed in adults.

show abstract

Section: Prophylactic Therapymentioning

confidence: 99%

How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Esto se añ adiría a la simplificació n y el abaratamiento progresivos de la té cnica, desde los primeros implantes de DAI epicá rdicos realizados en quiró fano a la era actual en que la mayoría de los implantes se practican en salas de electrofisiología 1 y sin necesidad de testar el umbral de desfibrilació n 22 . Y a ello se está n añ adiendo estrategias que ya son realidad, como la monitorizació n a distancia 23,24 y el desfibrilador subcutá neo 25,26 . …”

Section: Discusió Nunclassified

Seguridad del implante ambulatorio de desfibrilador automático implantable

Datino

Blanco

García

et al. 2015

Revista Española de Cardiología

View full text Add to dashboard Cite

“…Siguiendo nuestra política prioritaria de reforzar la formación médica continuada para nuestros lectores [1][2][3][4][5][6][7][8][9][10][11][12][13][14] , presentamos los resultados de los ensayos clínicos que se presentaron en secciones especiales (Late-Breaking Clinical Trials) en el congreso de 2014 de la American Heart Association celebrado en Chicago. Como en ediciones anteriores [15][16][17][18][19][20] describimos brevemente el objetivo principal, los métodos y los resultados, según lo recogido en las presentaciones orales.…”

unclassified